Growing community of inventors

Bengaluru, India

Siddhartha De

Average Co-Inventor Count = 9.60

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Siddhartha DeVenkata Poornapragnacharyulu Palle (2 patents)Siddhartha DeDebnath Bhuniya (2 patents)Siddhartha DeBhavesh Dave (2 patents)Siddhartha DeKasim A Mookhtiar (2 patents)Siddhartha DeGobind Sing Kapkoti (2 patents)Siddhartha DeSujay Basu (1 patent)Siddhartha DeSandeep Bhausaheb Bhosale (1 patent)Siddhartha DeKeshav Naik (1 patent)Siddhartha DeAnil M Deshpande (1 patent)Siddhartha DeSantosh Kurhade (1 patent)Siddhartha DeSachin Kandalkar (1 patent)Siddhartha DeBalasaheb Kobal (1 patent)Siddhartha DeAnita Chugh (1 patent)Siddhartha DeDebanath Bhuniya (0 patent)Siddhartha DeAnil Deshpande (0 patent)Siddhartha DeSiddhartha De (2 patents)Venkata Poornapragnacharyulu PalleVenkata Poornapragnacharyulu Palle (104 patents)Debnath BhuniyaDebnath Bhuniya (15 patents)Bhavesh DaveBhavesh Dave (7 patents)Kasim A MookhtiarKasim A Mookhtiar (6 patents)Gobind Sing KapkotiGobind Sing Kapkoti (2 patents)Sujay BasuSujay Basu (12 patents)Sandeep Bhausaheb BhosaleSandeep Bhausaheb Bhosale (7 patents)Keshav NaikKeshav Naik (4 patents)Anil M DeshpandeAnil M Deshpande (3 patents)Santosh KurhadeSantosh Kurhade (3 patents)Sachin KandalkarSachin Kandalkar (2 patents)Balasaheb KobalBalasaheb Kobal (2 patents)Anita ChughAnita Chugh (1 patent)Debanath BhuniyaDebanath Bhuniya (0 patent)Anil DeshpandeAnil Deshpande (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Advinus Therapeutics Private Limited (2 from 15 patents)


2 patents:

1. 8940900 - 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application

2. 8501955 - Acetamide derivatives as glucokinase activators, their process and medicinal application

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…